Les produits injectables et leur place dans le traitement de l'incontinence urinaire d'effort. [Bulking agents and their place in the treatment of urinary stress incontinence]

Détails

ID Serval
serval:BIB_F93A03013DFE
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Les produits injectables et leur place dans le traitement de l'incontinence urinaire d'effort. [Bulking agents and their place in the treatment of urinary stress incontinence]
Périodique
Gynakologisch-Geburtshilfliche Rundschau
Auteur⸱e⸱s
Achtari  C., Meyer  S., De Grandi  P.
ISSN
1018-8843 (Print)
Statut éditorial
Publié
Date de publication
2006
Volume
46
Numéro
1-2
Pages
39-44
Notes
English Abstract
Journal Article
Meta-Analysis
Résumé
Bulking agents are used in the treatment of urinary stress incontinence associated with intrinsic sphincter deficiency. Bovine collagen remains the gold standard despite problems such as allergic reaction and absorption of the injected material. Several new products are being evaluated or used clinically to try and overcome problems linked with bovine collagen. The aim of this paper is to review the bulking agents available and to put in prospect use of these products with the recent progress made in the treatment of urinary stress incontinence. The gold standard treatment for intrinsic sphincter deficiency is suburethral autologous or synthetic suburethral slings. Bulking agents are indicated for multi-operated patients with urinary stress incontinence and intrinsic sphincter deficiency. Bladder neck hypermobility is not a contraindication.
Mots-clé
*Biocompatible Materials Female Follow-Up Studies Humans Injections *Prostheses and Implants Recurrence Retreatment Urethra Urinary Incontinence, Stress/physiopathology/*therapy Urodynamics/physiology
Pubmed
Création de la notice
25/01/2008 15:39
Dernière modification de la notice
20/08/2019 16:25
Données d'usage